Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

New England Journal of Medicine

Volumn 324, Issue 12, 1991, Pages 808-815

  Lipshultz, Steven E ^a   Colan, Steven D ^a   Sanders, Stephen P ^a   Perez Atayde, Antonio R ^b   Sallan, Stephen E ^c   Gelber, Richard D ^d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b Department of Pathology ^*  (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE DRUG REACTION; ARTICLE; CARDIOTOXICITY; CHILD; DRUG SAFETY; DRUG TOXICITY; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CHILD; DOXORUBICIN; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; HEART FAILURE, CONGESTIVE; HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LOGISTIC MODELS; MYOCARDIAL CONTRACTION; MYOCARDIUM; RISK FACTORS; STROKE VOLUME; SUPPORT, U.S. GOV'T, P.H.S.; VENTRICULAR FUNCTION, LEFT;

EID: 0026031848     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199103213241205     Document Type: Article

References (37)

1. Hitchcock-Bryan S., Gelber R.D., Cassady J.R., Sallan S.E. The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1986; 14:211-215
2. Riehm H., Gadner H., Henze G., et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Hamatol Bluttransfus 1990; 33:439-450
3. Kantrowitz N.E., Bristow M.R. Cardiotoxicity of antitumor agents. Prog Cardiovasc Dis 1984; 27:195-200.
4. Lefrak E.A., Pitha J., Rosenheim S., Gottlieb J.A. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973; 32:302-314
5. Lewis A.B., Pilkington R., Takahashi M., Siegel S.E. Echocardiographic assessment of anthracycline cardiotoxicity in children. Med Pediatr Oncol 1978; 5:167-175
6. Bristow M.R., Thompson P.D., Martin R.P., Mason J.W., Billingham M.E., Harrison D.C. Early anthracycline cardiotoxicity. Am J Med 1978; 65:823-832
7. Bristow M.R., Billingham M.E., Mason J.W., Daniels J.R. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 1978; 62:873-879
8. Gilladoga AC, Manuel C., Tan C.T.C., Wollner N., Sternberg S.S., Murphy M.L. The cardiotoxicity of adriamycin and daunomycin in children. Cancer 1976; 37:1070-1078
9. Von Hoff D.D., Layard M.W., Basa P., et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 91:710-717
10. Furman L., Camitta B.M., Jaffe N., et al. Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report. Med Pediatr Oncol 1976; 2:157-166
11. Sallan S.E., Camitta B.M., Cassady J.R., Nathan D.G., Frei E. III. Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. Blood 1978; 51:425-433
12. Sallan S.E., Hitchcock-Bryan S., Gelber R.D., Cassady J.R., Frei E. III, Nathan D.G. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res 1983; 43:5601-5607
13. Sallan S.E., Clavell L.A., Gelber R., Hitchcock-Bryan S., Cassady J.R. Intensive chemotherapy in childhood ALL. In: Wehinger J, ed. Leukämiebehandlung im Kindesalter: Stand zu Beginn der 80er Jahre. Friedrichsdorf/Taunus, Germany: Milupa AG, 1984: 35-43.
14. Clavell L.A., Gelber R.D., Cohen H.J., et al. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 1986; 315:657-663
15. Sallan S.E., Gelber R.D., Blattner S., Clavell L., Cohen H.J. Childhood acute lymphoblastic leukemia: value of intensive induction therapy. Blood 1989; 74:Suppl:79a. abstract.
16. Davignon A., Rautaharju P., Boisselle E., Soumis F., Megelas M., Choquette A. Normal ECG standards for infants and children. Pediatr Cardiol 1980; 1:123-131
17. Bruce R.A., Blackmon J.R., Jones J.W., Strait G. Exercise testing in adult normal subjects and cardiac patients. Pediatrics 1963; 32:742-756
18. Colan S.D., Borow K.M., Neumann A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 1984; 4:715-724
19. Cumming G.R., Everatt D., Hastman L. Bruce treadmill test in children: normal values in a clinic population. Am J Cardiol 1978; 41:69-75.
20. James F.W., Kaplan S., Glueck C.J., Tsay J.Y., Knight M.J., Sarwar C.J. Response of normal children and young adults to controlled bicycle exercise. Circulation 1980; 61:902-912
21. Cox D.R., Snell E.J. Analysis of binary data. 2nd ed. London: Chapman and Hall, 1989.
22. Lown B., Graboys T.B. Management of patients with malignant ventricular arrhythmias. Am J Cardiol 1977; 39:910-918
23. Wetherbee J.N., Bamrah V.S., Ptacin M.J., Kalbfleisch J.H. Comparison of ST segment depression in upright treadmill and supine bicycle exercise testing. J Am Coll Cardiol 1988; 11:330-337
24. Goorin A.M., Chauvenet A.R., Perez-Atayde A.R., Cruz J., McKone R., Lipshultz S.E. Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer. J Pediatr 1990; 116:144-147
25. Hausdorf G., Morf G., Beron G., et al. Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling. Br Heart J 1988; 60:309-315
26. Lipshultz S.E., Colan S.D., Sanders S.P., Sallan S.E. Cardiac mechanics after growth hormone therapy in pediatric adriamycin recipients. Pediatr Res 1989; 25:Suppl:153A. abstract.
27. Borow K.M., Colan S.D., Neumann A. Altered left ventricular mechanics in patients with valvular aortic stenosis and coarctation of the aorta: effects on systolic performance and late outcome. Circulation 1985; 72:515-522
28. Zak R. Development of proliferative capacity of cardiac muscle cells. Circ Res 1974; 35:Suppl II:II–17-II-26.
29. Clubb F.J. Jr., Bishop S.P. Formation of binucleated myocardial cells in the neonatal rat: an index for growth hypertrophy. Lab Invest 1984; 50:571-577
30. Clubb F.J. Jr., Bell P.D., Kriseman J.D., Bishop S.P. Myocardial cell growth and blood pressure development in neonatal spontaneously hypertensive rats. Lab Invest 1987; 56:189-197
31. Koh E., Imashuku S., Kiyosawa N., Sawada T. Anthracycline-induced congestive heart failure in two pediatric leukemia cases and long-term follow-up. Pediatr Hematol Oncol 1988; 5:245-251
32. Caulfield J.B., Bittner V. Cardiac matrix alterations induced by adriamycin. Am J Pathol 1988; 133:298-305.
33. Nag AC. Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 1980; 28:41-61.
34. Lipshultz S.E., Colan S.D., Sanders S.P., Sallan S.E. Late cardiac effects of doxorubicin in childhood acute lymphoblastic leukemia. Blood 1987; 70:Suppl:234a. abstract.
35. Lipshultz S.E., Colan S.D., Sanders S.P., Perez-Atayde A., Sallan S.E. Late myocardial growth impairment in children treated with adriamycin(adr). Am J Cardiol 1989; 64:416. abstract.
36. Lipshultz S.E., Colan S.D., Walsh E.P., Sanders S.P., Sallan S.E. Ventricular tachycardia and sudden unexplained death in late survivors of childhood malignancy treated with doxorubicin. Pediatr Res 1990; 27:Suppl:145A. abstract.
37. Steinherz L.J., Steinherz P. Cardiac failure more than six years post anthracyclines. Am J Cardiol 1988; 62:505. abstract.